Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin and Hydroxychloroquine in Hospitalized COVID-19 Patients
NCT04322396Phase 2Terminated
- Sponsor
- COPD360Net
- Start
- Apr 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azithromycin, hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by COPD360Net. Started Apr 2020; status: terminated.
02
Drugs
azithromycinhydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04322396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322396.